Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Condition(s):UveitisLast Updated:July 12, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):UveitisLast Updated:July 12, 2016Terminated
Condition(s):PsoriasisLast Updated:March 31, 2022Recruiting
Condition(s):Breast CancerLast Updated:August 7, 2009Unknown status
Condition(s):18F-FAPI; Pancreas Adenocarcinoma; Systemic Treatment; Pathologic ResponseLast Updated:February 26, 2024Completed
Condition(s):Neuropathic PainLast Updated:October 9, 2019Completed
Condition(s):Neuropathic PainLast Updated:April 28, 2021Terminated
Condition(s):Breast CancerLast Updated:April 6, 2023Active, not recruiting
Condition(s):Cancer; Self EfficacyLast Updated:November 14, 2019Completed
Condition(s):Metastatic Renal Cell Carcinoma; RadiotherapyLast Updated:August 1, 2023Recruiting
Condition(s):PsoriasisLast Updated:October 15, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.